FTC to Investigate CVS Caremark and Other Pharmacy-Benefit Managers

The Federal Trade Commission is probing CVS Caremark, CVS 0.94%▲ Express Scripts Inc. and other large pharmacy-benefits managers over what impact their business models have on the accessibility and affordability of prescription drugs.


Read the full story >